Skip to main content
ALHC
NASDAQ Finance

Alignment Healthcare Exceeds Q4 & FY2025 Guidance, Raises 2026 Membership Outlook

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$20.31
Mkt Cap
$4.086B
52W Low
$11.625
52W High
$23.87
Market data snapshot near publication time

summarizeSummary

Alignment Healthcare announced Q4 and full-year 2025 results that beat guidance across all key metrics, significantly improved profitability, and raised its 2026 membership and financial outlook.


check_boxKey Events

  • Exceeded Q4 and Full-Year 2025 Guidance

    The company surpassed the high end of its guidance for Q4 and full-year 2025 across all key metrics, including health plan membership (236,300, up 25.0% YoY), total revenue ($1,012.8M for Q4, $3,948.7M for FY2025), adjusted gross profit, and adjusted EBITDA.

  • Significant Profitability Improvement

    Alignment Healthcare dramatically reduced its full-year net loss from $128.071 million in 2024 to $1.0 million in 2025. Adjusted EBITDA for the full year 2025 reached $109.9 million, a substantial increase from $1.339 million in 2024.

  • Raised 2026 Guidance

    The company raised its health plan membership guidance for 2026 by 2,000 at the midpoint, now expecting 292,000 to 298,000 members. It also introduced 2026 revenue guidance of $5.14 billion to $5.19 billion (30%-31% growth) and adjusted EBITDA of $133 million to $163 million.


auto_awesomeAnalysis

Alignment Healthcare reported strong financial results for the fourth quarter and full year 2025, significantly exceeding the high end of its guidance across all key metrics including membership, revenue, adjusted gross profit, and adjusted EBITDA. The company demonstrated substantial progress towards profitability, reducing its full-year net loss from over $128 million in 2024 to just $1.0 million in 2025, while Adjusted EBITDA surged to nearly $110 million. Furthermore, the company raised its health plan membership guidance for 2026 and provided robust revenue and Adjusted EBITDA forecasts, signaling continued strong growth and improved operational efficiency. This performance indicates a positive trajectory and could lead to increased investor confidence.

At the time of this filing, ALHC was trading at $20.31 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALHC - Latest Insights

ALHC
Apr 24, 2026, 10:52 AM EDT
Filing Type: DEF 14A
Importance Score:
7
ALHC
Mar 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
ALHC
Mar 03, 2026, 3:13 PM EST
Filing Type: 424B7
Importance Score:
7
ALHC
Mar 02, 2026, 9:05 PM EST
Source: GlobeNewswire
Importance Score:
7
ALHC
Mar 02, 2026, 4:49 PM EST
Source: Reuters
Importance Score:
7
ALHC
Feb 26, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
ALHC
Jan 12, 2026, 9:10 AM EST
Filing Type: 8-K
Importance Score:
7